Compounds > bms204352
Page last updated: 2024-09-05

bms204352 and domperidone

bms204352 has been researched along with domperidone in 2 studies

Compound Research Comparison

Studies
(bms204352)		Trials
(bms204352)		Recent Studies (post-2010)
(bms204352)		Studies
(domperidone)		Trials
(domperidone)		Recent Studies (post-2010) (domperidone)
491121,977275468

Protein Interaction Comparison

ProteinTaxonomybms204352 (IC50)domperidone (IC50)
Solute carrier family 22 member 2Homo sapiens (human)7.9
5-hydroxytryptamine receptor 4Cavia porcellus (domestic guinea pig)1.332
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)2.614
Alpha-2A adrenergic receptorHomo sapiens (human)2.74
D(2) dopamine receptorHomo sapiens (human)0.0026
Alpha-2B adrenergic receptorHomo sapiens (human)2.125
Alpha-2C adrenergic receptorHomo sapiens (human)1.011
Sodium-dependent noradrenaline transporter Homo sapiens (human)2.614
Alpha-1D adrenergic receptorHomo sapiens (human)1.065
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.037
5-hydroxytryptamine receptor 2CHomo sapiens (human)1.332
Sodium-dependent serotonin transporterHomo sapiens (human)3.055
Histamine H1 receptorHomo sapiens (human)1.344
Mu-type opioid receptorHomo sapiens (human)4.218
D(3) dopamine receptorHomo sapiens (human)0.018
Kappa-type opioid receptorHomo sapiens (human)6.994
5-hydroxytryptamine receptor 2BHomo sapiens (human)2.6
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0052
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)0.1447
Multidrug and toxin extrusion protein 1Homo sapiens (human)2.3

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1

Other Studies

2 other study(ies) available for bms204352 and domperidone

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013